Identifying Androgen Receptor (AR) and Genomic Characteristics That Define Populations of Patients with Mhspc Who Benefit from Early PARP Inhibition Therapy with Talazoparib.
Journal of Clinical Oncology（2021）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要